Development of Serum DHCR24 Antibody as a Marker for Hepatocellular Carcinoma: The End of the Beginning

by Stephen L. Chan, Anthony W.H. Chan
Published 2015-06-01

What do oncologists need to know about biosimilar products?

by Linda K. S. Leung, Kevin Mok, Calvin Liu, Stephen L. Chan
Published 2016-10-01

The association of liver function and quality of life of patients with liver cancer

by Leung Li, Frankie Mo, Edwin P. Hui, Stephen L. Chan, Jane Koh, Nelson L. S. Tang, Simon C. H. Yu, Winnie Yeo
Published 2019-05-01

Baseline Liver Function and Subsequent Outcomes in the Phase 3 REFLECT Study of Patients with Unresectable Hepatocellular Carcinoma

by Arndt Vogel, Catherine Frenette, Max Sung, Bruno Daniele, Ari Baron, Stephen L. Chan, Jean Frédéric Blanc, Toshiyuki Tamai, Min Ren, Howard J. Lim, Daniel H. Palmer, Yuko Takami, Masatoshi Kudo
Published 2021-07-01

Albumin-to-Alkaline Phosphatase Ratio: A Novel Prognostic Index for Hepatocellular Carcinoma

by Anthony W. H. Chan, Stephen L. Chan, Frankie K. F. Mo, Grace L. H. Wong, Vincent W. S. Wong, Yue-Sun Cheung, Henry L. Y. Chan, Winnie Yeo, Paul B. S. Lai, Ka-Fai To
Published 2015-01-01

Applications of genetic-epigenetic tissue mapping for plasma DNA in prenatal testing, transplantation and oncology

by Wanxia Gai, Ze Zhou, Sean Agbor-Enoh, Xiaodan Fan, Sheng Lian, Peiyong Jiang, Suk Hang Cheng, John Wong, Stephen L Chan, Moon Kyoo Jang, Yanqin Yang, Raymond HS Liang, Wai Kong Chan, Edmond SK Ma, Tak Y Leung, Rossa WK Chiu, Hannah Valantine, KC Allen Chan, YM Dennis Lo
Published 2021-03-01

Effect of ramucirumab on ALBI grade in patients with advanced HCC: Results from REACH and REACH-2

by Masatoshi Kudo, Peter R. Galle, Giovanni Brandi, Yoon-Koo Kang, Chia-Jui Yen, Richard S. Finn, Josep M. Llovet, Eric Assenat, Philippe Merle, Stephen L. Chan, Daniel H. Palmer, Masafumi Ikeda, Tatsuya Yamashita, Arndt Vogel, Yi-Hsiang Huang, Paolo B. Abada, Reigetsu Yoshikawa, Kenta Shinozaki, Chunxiao Wang, Ryan C. Widau, Andrew X. Zhu
Published 2021-04-01